Phase I/II study of PF-06463922, an ALK/ROS1 tyrosine kinase inhibitor, in patients with advanced non-small-cell lung cancer harboring specific molecular alterations.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS2620-TPS2620 ◽  
Author(s):  
Todd Michael Bauer ◽  
Alice Tsang Shaw ◽  
Ben Solomon ◽  
Benjamin Besse ◽  
Leonard P. James ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Molecular Alterations

Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment

2019 ◽  
Vol 133 ◽  
pp. 145-159 ◽  
Author(s):  
Nishant S. Kulkarni ◽  
Vineela Parvathaneni ◽  
Snehal K. Shukla ◽  
Leonard Barasa ◽  
Jeanette C. Perron ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Quantum Dots ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung

Tyrosine Kinase Inhibitor Gold Nanoconjugates for the Treatment of Non-Small Cell Lung Cancer

2019 ◽  
Vol 11 (18) ◽  
pp. 16336-16346 ◽  
Author(s):  
Alexander M. Cryer ◽  
Cheuk Chan ◽  
Anastasia Eftychidou ◽  
Christy Maksoudian ◽  
Mohan Mahesh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung

Absence of EGFR C797S Mutation in Tyrosine Kinase Inhibitor-Naïve Non–Small Cell Lung Cancer Tissues

2019 ◽  
Vol 26 (2) ◽  
pp. 1229-1234 ◽  
Author(s):  
Igor P. Oscorbin ◽  
Alexandra S. Shadrina ◽  
Vadim V. Kozlov ◽  
Vladimir E. Voitsitsky ◽  
Maxim L. Filipenko
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cancer Tissues
Sign in / Sign up

Export Citation Format

Share Document